These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11582577

  • 41. Cholecystokinin and gastrin receptors.
    Dufresne M, Seva C, Fourmy D.
    Physiol Rev; 2006 Jul; 86(3):805-47. PubMed ID: 16816139
    [Abstract] [Full Text] [Related]

  • 42. NMR studies of CCK-8/CCK1 complex support membrane-associated pathway for ligand-receptor interaction.
    Giragossian C, Pellegrini M, Mierke DF.
    Can J Physiol Pharmacol; 2002 May; 80(5):383-7. PubMed ID: 12056543
    [Abstract] [Full Text] [Related]

  • 43. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M, Behr TM.
    Biopolymers; 2002 May; 66(6):399-418. PubMed ID: 12658727
    [Abstract] [Full Text] [Related]

  • 44. Amphiphilic CCK peptides assembled in supramolecular aggregates: structural investigations and in vitro studies.
    Accardo A, Morisco A, Palladino P, Palumbo R, Tesauro D, Morelli G.
    Mol Biosyst; 2011 Mar; 7(3):862-70. PubMed ID: 21157624
    [Abstract] [Full Text] [Related]

  • 45. In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with 99mTc-tricarbonyl.
    D'Andrea LD, Testa I, Panico M, Di Stasi R, Caracò C, Tarallo L, Arra C, Barbieri A, Romanelli A, Aloj L.
    Biopolymers; 2008 Mar; 90(5):707-12. PubMed ID: 18615495
    [Abstract] [Full Text] [Related]

  • 46. Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor.
    Harikumar KG, Pinon DI, Miller LJ.
    Biosci Rep; 2006 Apr; 26(2):89-100. PubMed ID: 16779661
    [Abstract] [Full Text] [Related]

  • 47. Insights into the molecular basis of ligand binding by the cholecystokinin receptor.
    Miller LJ, Ding XQ.
    Pancreatology; 2001 Apr; 1(4):336-42. PubMed ID: 12120212
    [Abstract] [Full Text] [Related]

  • 48. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
    Reeve JR, Liddle RA, McVey DC, Vigna SR, Solomon TE, Keire DA, Rosenquist G, Shively JE, Lee TD, Chew P, Green GM, Coskun T.
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
    [Abstract] [Full Text] [Related]

  • 49. Identical primary sequence but different conformations of the bioactive regions of canine CCK-8 and CCK-58.
    Keire DA, Solomon TE, Reeve JR.
    Biochem Biophys Res Commun; 1999 Dec 20; 266(2):400-4. PubMed ID: 10600515
    [Abstract] [Full Text] [Related]

  • 50. Sequence variation outside the "active" region of dog and rabbit cholecystokinin-58 results in bioactivity differences.
    Reeve JR, Liddle RA, Shively JE, Lee TD, Keire DA, Chew P, Vigna SR.
    Pancreas; 2006 Apr 20; 32(3):306-13. PubMed ID: 16628087
    [Abstract] [Full Text] [Related]

  • 51. CCK8 peptide derivatized with diphenylphosphine for rhenium labelling: synthesis and molecular mechanics calculations.
    Morelli G, De Luca S, Tesauro D, Saviano M, Pedone C, Dolmella A, Visentin R, Mazzi U.
    J Pept Sci; 2002 Jul 20; 8(7):373-81. PubMed ID: 12148786
    [Abstract] [Full Text] [Related]

  • 52. Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors.
    Knight M, Tamminga CA, Steardo L, Beck ME, Barone P, Chase TN.
    Eur J Pharmacol; 1984 Oct 01; 105(1-2):49-55. PubMed ID: 6092115
    [Abstract] [Full Text] [Related]

  • 53. Influence of PEG length on conformational and binding properties of CCK peptides exposed by supramolecular aggregates.
    Accardo A, Ringhieri P, Palumbo R, Morelli G.
    Biopolymers; 2014 Jul 01; 102(4):304-12. PubMed ID: 24752531
    [Abstract] [Full Text] [Related]

  • 54. NMR evidence for different conformations of the bioactive region of rat CCK-8 and CCK-58.
    Keire DA, Solomon TE, Reeve JR.
    Biochem Biophys Res Commun; 2002 May 10; 293(3):1014-20. PubMed ID: 12051761
    [Abstract] [Full Text] [Related]

  • 55. Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification.
    Gimpl G, Anders J, Thiele C, Fahrenholz F.
    Eur J Biochem; 1996 May 01; 237(3):768-77. PubMed ID: 8647124
    [Abstract] [Full Text] [Related]

  • 56. Structure activity of C-terminal modified analogs of Ac-CCK-7.
    Tilley JW, Danho W, Shiuey SJ, Kulesha I, Sarabu R, Swistok J, Makofske R, Olson GL, Chiang E, Rusiecki VK.
    Int J Pept Protein Res; 1992 Apr 01; 39(4):322-36. PubMed ID: 1385345
    [Abstract] [Full Text] [Related]

  • 57. Essential role of extracellular charged residues of the human CCK(1) receptor for interactions with SR 146131, SR 27897 and CCK-8S.
    Gouldson P, Legoux P, Carillon C, Dumont X, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 2000 Feb 18; 389(2-3):115-24. PubMed ID: 10688974
    [Abstract] [Full Text] [Related]

  • 58. In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging.
    Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M.
    Cancer Biother Radiopharm; 2004 Feb 18; 19(1):93-8. PubMed ID: 15068617
    [Abstract] [Full Text] [Related]

  • 59. Synthesis and solution characterization of a porphyrin-CCK8 conjugate.
    De Luca S, Tesauro D, Di Lello P, Fattorusso R, Saviano M, Pedone C, Morelli G.
    J Pept Sci; 2001 Jul 18; 7(7):386-94. PubMed ID: 11495499
    [Abstract] [Full Text] [Related]

  • 60. Pig brain contains cholecystokinin octapeptide and several cholecystokinin desoctapeptides.
    Eng J, Shiina Y, Pan YC, Blacher R, Chang M, Stein S, Yalow RS.
    Proc Natl Acad Sci U S A; 1983 Oct 18; 80(20):6381-5. PubMed ID: 6312456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.